Cronos Group Inc. (CRON) Earns Buy Rating and C$4.50 PT on Scalable Model

Core Insights - Cronos Group Inc. (NASDAQ:CRON) is recognized as one of the best pot stocks to buy according to hedge funds, with 19 hedge funds holding stakes in the company as of Q3 2025 [4] Group 1: Analyst Ratings and Price Targets - TD Securities initiated coverage of Cronos Group with a Buy rating and a price target of C$4.50, highlighting its portfolio of iconic Canadian cannabis brands and scalable cost structure [2] - Canaccord analyst Kenric Tyghe also initiated coverage with a Buy rating and a price target of C$4.25, emphasizing the importance of the acquisition of CanAdelaar and the expansion of Cronos Growing Company for enhancing vertical integration and international reach [3] Group 2: Company Overview - Founded in 2012 and headquartered in Toronto, Cronos Group Inc. is a cannabinoid company that cultivates, produces, and markets cannabis products globally, offering a range of products including dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under brands like Spinach, Lord Jones, and PEACE NATURALS [4]